Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined Array Biopharma's (Nasdaq: ARRY) board of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Changes

Array Biopharma, Inc. (ARRY) Posts Q3 Loss of 20c/ShareApril 29, 2014 8:07 AM